SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

01 Aug 2025 Evaluate
The company witnessed a 14.57% growth in the revenue at Rs. 1008.58 millions for the quarter ended June 2025 as compared to Rs. 880.34 millions during the year-ago period.The Net Profit of the company registered a slight decline of -2.31% to Rs. 76.45  millions from Rs. 78.26 millions.Operating Profit saw a handsome growth to 143.71 millions from 125.85 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1008.58 880.34 14.57 1008.58 880.34 14.57 3592.94 3289.73 9.22
Other Income 65.53 62.67 4.56 65.53 62.67 4.56 97.58 159.01 -38.63
PBIDT 143.71 125.85 14.19 143.71 125.85 14.19 354.59 601.94 -41.09
Interest 12.08 4.43 172.69 12.08 4.43 172.69 23.07 13.38 72.42
PBDT 131.63 121.42 8.41 131.63 121.42 8.41 331.52 588.56 -43.67
Depreciation 34.47 21.40 61.07 34.47 21.40 61.07 92.70 81.48 13.77
PBT 97.16 100.02 -2.86 97.16 100.02 -2.86 238.82 507.08 -52.90
TAX 20.71 21.76 -4.83 20.71 21.76 -4.83 57.50 121.89 -52.83
Deferred Tax 13.52 3.51 285.19 13.52 3.51 285.19 4.06 7.76 -47.68
PAT 76.45 78.26 -2.31 76.45 78.26 -2.31 181.32 385.19 -52.93
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 14.25 14.30 -0.33 14.25 14.30 -0.33 9.87 18.30 -46.06

NGL Fine-Chem Share Price

2329.30 -41.85 (-1.76%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×